Table 2 Mineral Appositional rates (mean ± standard deviation) is shown in the neck of the femur from Wistar rats in the controls and type 1 diabetes at four (A-DM), twelve (B-DM) and twenty-four (C-DM) weeks of the duration of diabetes.
From: In vivo Labeling of Bone Microdamage in an Animal Model of Type 1 Diabetes Mellitus
Control | Diabetic | |||||
|---|---|---|---|---|---|---|
A 4 week | B 12 week | C 24 week | Gp A-DM 4 week | Gp B-DM 12 week | GP C-DM 24 week | |
Mean length of microcracks (Cr.Le) µm | 36.25 ± 9.7 | 37.22 ± 7.1 | 41.27 ± 8.6 | 39.52 ± 9.3 | 44 ± 8.78 | 69.81 ± 13.5 |
Mean crack numerical density (Cr.N.Dn) (mm2) | 0.16 ± 0.07 | 0.15 ± 0.03 | 0.21 ± 0.03 | 0.48 ± 0.06 | 0.29 ± 0.15 | 0.23 ± 0.05 |
Mean crack surface density (Cr.S.Dn) (mm2) | 5.95 ± 2.52 | 6.11 ± 0.28 | 8.91 ± 1.7 | 15.32 ± 1.8 | 12.79 ± 5.6 | 16.44 ± 3.6 |
Mean diffuse damage density (Dx.Dn) (mm2) | 0.04 ± 0.06 | 0.04 ± 0.03 | 0.3 ± 0.08 | 0.20 ± 0.01 | 0.41 ± 0.15 | 0.23 ± 0.11 |
